Demystifying the Results Obtained through the Use of SGLT-2 Inhibitor Drugs, Used by Patients at the Reference Center for Hypertension and Diabetes Rio Verde - Goiás. RSD 2023, 12 (12), e76121243964. https://doi.org/10.33448/rsd-v12i12.43964.